These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11510916)

  • 1. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis.
    Lai KN; Ho K; Cheung RC; Lit LC; Lee SK; Fung KS; Tong MK; Lam CW
    Int J Artif Organs; 2001 Jul; 24(7):447-55. PubMed ID: 11510916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin reduces triglyceride, VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.
    Yang C; Wu T; Huang C
    Am J Nephrol; 1998; 18(5):384-90. PubMed ID: 9730561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis.
    Leu JG; Liou HH; Wu SC; Yang WC; Huang TP; Wu SC
    J Formos Med Assoc; 1998 Jan; 97(1):49-54. PubMed ID: 9481065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients.
    Yang S; Niu Q; Gan L; Zhang X; Tu L; Zuo L
    Hemodial Int; 2020 Jul; 24(3):374-382. PubMed ID: 32520445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Meisl T; Pinter G; Dieplinger H
    Thromb Haemost; 1995 Oct; 74(4):1025-8. PubMed ID: 8560405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients.
    Elisaf MS; Germanos NP; Bairaktari HT; Pappas MB; Koulouridis EI; Siamopoulos KC
    Am J Nephrol; 1997; 17(2):153-7. PubMed ID: 9096446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.
    Akiba T; Tachibana K; Ozawa K; Chida Y; Ogasawara H; Yoshiyama N; Hoshino M; Inada T; Marumo F
    ASAIO J; 1992; 38(3):M326-30. PubMed ID: 1333845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of low molecular weight heparin on serum lipids in hypertriglyceridemic chronic hemodialysis patients.
    Vlassopoulos D; Noussias C; Hadjipetrou A; Arvanitis D; Logothetis E; Magana P; Katopodis K; Hadjiconstantinou V
    J Nephrol; 1997; 10(2):111-4. PubMed ID: 9238618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and Bone Effects of Heparin Use During Hemodialysis.
    Stegmayr B; Zuo L; Zadora W
    Semin Nephrol; 2023 Nov; 43(6):151480. PubMed ID: 38195305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
    Schmitt Y; Schneider H
    Nephrol Dial Transplant; 1993; 8(5):438-42. PubMed ID: 8393549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept.
    Leitienne P; Fouque D; Rigal D; Adeleine P; Trzeciak MC; Laville M
    Nephrol Dial Transplant; 2000 Oct; 15(10):1631-7. PubMed ID: 11007833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
    Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
    Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
    Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
    Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
    Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population.
    Abo-Zenah H; Sabry A; Farouk A; Abdelhalim N; El-Sayed K; Sobh M
    Int Urol Nephrol; 2007; 39(2):609-18. PubMed ID: 17279435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of low molecular weight heparin on lipid parameters in hemodialysis patients.
    Elisaf MS; Bairaktari H; Germanos N; Pappas M; Koulouridis E; Papagalanis N; Siamopoulos KC
    Int Angiol; 1996 Sep; 15(3):252-6. PubMed ID: 8971586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.